Systemic inflammation, coagulopathy, and acute renal insufficiency following endovascular thoracoabdominal aortic aneurysm repair

Journal of Vascular Surgery

Volumn 49, Issue 5, 2009, Pages 1140-1146

  Chang, Catherine K ^a   Chuter, Timothy A M ^a   Niemann, Claus U ^a,c   Shlipak, Michael G ^b   Cohen, Mitchell J ^a   Reilly, Linda M ^a   Hiramoto, Jade S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5; CYSTATIN C; D DIMER; INTERLEUKIN 6; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PROTEIN C;

ACUTE KIDNEY FAILURE; ADULT; AGED; AORTA ANEURYSM; AORTA GRAFT; AORTA SURGERY; ARTICLE; BLOOD CLOTTING DISORDER; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; ENDOVASCULAR SURGERY; HUMAN; INFLAMMATION; KIDNEY FUNCTION; KIDNEY INJURY; LEUKOCYTE COUNT; LEUKOCYTOSIS; MORTALITY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTHROMBIN TIME; THORACOABDOMINAL AORTA ANEURYSM; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ACUTE-PHASE PROTEINS; AGED; AGED, 80 AND OVER; AORTIC ANEURYSM, THORACIC; BIOLOGICAL MARKERS; BLOOD COAGULATION DISORDERS; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CREATININE; CYSTATIN C; FACTOR V; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; INTERLEUKIN-6; LEUKOCYTE COUNT; LEUKOCYTOSIS; LIPOCALINS; MALE; PLATELET COUNT; PROSTHESIS DESIGN; PROTEIN C; PROTHROMBIN TIME; PROTO-ONCOGENE PROTEINS; RENAL INSUFFICIENCY, ACUTE; STENTS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTOPENIA; TIME FACTORS; TREATMENT OUTCOME;

EID: 64949138920     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2008.11.102     Document Type: Article

References (28)

1. Crawford E.S., and DeNatale R.W. Thoracoabdominal aortic aneurysm: observations regarding the natural course of the disease. J Vasc Surg 3 (1986) 578-582
2. Rigberg D.A., McGory M.L., Zingmond D.S., Maggard M.A., Agustin M., Lawrence P.F., and Ko C.Y. Thirty-day mortality statistics underestimate the risk of repair of thoracoabdominal aortic aneurysms: a statewide experience. J Vasc Surg 43 (2006) 217-222 discussion 223.
3. Chuter T.A., and Reilly L.M. Endovascular treatment of thoracoabdominal aortic aneurysms. J Cardiovasc Surg (Torino) 47 (2006) 619-628
4. Roselli E.E., Greenberg R.K., Pfaff K., Francis C., Svensson L.G., and Lytle B.W. Endovascular treatment of thoracoabdominal aortic aneurysms. J Thorac Cardiovasc Surg 133 (2007) 1474-1482
5. Chuter T.A., Rapp J.H., Hiramoto J.S., Schneider D.B., Howell B., and Reilly L.M. Endovascular treatment of thoracoabdominal aortic aneurysms. J Vasc Surg 47 (2008) 6-16
6. Peterson B.G., Matsumura J.S., Brewster D.C., and Makaroun M.S. Five-year report of a multicenter controlled clinical trial of open versus endovascular treatment of abdominal aortic aneurysms. J Vasc Surg 45 (2007) 885-890
7. Hiramoto J.S., Reilly L.M., Schneider D.B., Sivamurthy N., Rapp J.H., and Chuter T.A. Long-term outcome and reintervention after endovascular abdominal aortic aneurysm repair using the Zenith stent graft. J Vasc Surg 45 (2007) 461-465 discussion 465-6.
8. Blum U., Voshage G., Lammer J., Beyersdorf F., Töllner D., Kretschmer G., et al. Endoluminal stent-grafts for infrarenal abdominal aortic aneurysms. N Engl J Med 336 (1997) 13-20
9. Velazquez O.C., Carpenter J.P., Baum R.A., Barker C.F., Golden M., Criado F., et al. Perigraft air, fever, and leukocytosis after endovascular repair of abdominal aortic aneurysms. Am J Surg 178 (1999) 185-189
10. Galle C., De Maertelaer V., Motte S., Zhou L., Stordeur P., Delville J.P., et al. Early inflammatory response after elective abdominal aortic aneurysm repair: a comparison between endovascular procedure and conventional surgery. J Vasc Surg 32 (2000) 234-246
11. Swartbol P., Norgren L., Albrechtsson U., Cwikiel W., Jahr J., Jonung T., et al. Biological responses differ considerably between endovascular and conventional aortic aneurysm surgery. Eur J Vasc Endovasc Surg 12 (1996) 18-25
12. Norgren L., Albrechtsson U., and Swartbol P. Side-effect of endovascular grafting to treat aortic aneurysm. Br J Surg 83 (1996) 520-521
13. Gerasimidis T., Sfyroeras G., Trellopoulos G., Skoura L., Papazoglou K., Konstantinidis K., et al. Impact of endograft material on the inflammatory response after elective endovascular abdominal aortic aneurysm repair. Angiology 56 (2005) 743-753
14. Cross K.S., Bouchier-Hayes D., and Leahy A.L. Consumptive coagulopathy following endovascular stent repair of abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 19 (2000) 94-95
15. Liu K.D., Glidden D.V., Eisner M.D., Parsons P.E., Ware L.B., Wheeler A., et al. Predictive and pathogenetic value of plasma biomarkers for acute kidney injury in patients with acute lung injury. Crit Care Med 35 (2007) 2755-2761
16. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
17. Morikage N., Esato K., Zenpo N., Fujioka K., and Takenaka H. Is endovascular treatment of abdominal aortic aneurysms less invasive regarding the biological responses?. Surg Today 30 (2000) 142-146
18. Swartbol P., Truedsson L., and Norgren L. Adverse reactions during endovascular treatment of aortic aneurysms may be triggered by interleukin 6 release from the thrombotic content. J Vasc Surg 28 (1998) 664-668
19. Nguyen M.T., and Devarajan P. Biomarkers for the early detection of acute kidney injury. Pediatr Nephrol 23 (2008) 2151-2157
20. Trof R.J., Di Maggio F., Leemreis J., and Groeneveld A.B. Biomarkers of acute renal injury and renal failure. Shock 26 (2006) 245-253
21. Coll E., Botey A., Alvarez L., Poch E., Quintó L., Saurina A., et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 36 (2000) 29-34
22. Chantrel F., Agin A., Offner M., Koehl C., Moulin B., and Hannedouche T. Comparison of cystatin C versus creatinine for detection of mild renal failure. Clin Nephrol 54 (2000) 374-381
23. Harmoinen A.P., Kouri T.T., Wirta O.R., Lehtimäki T.J., Rantalaiho V., Turjanmaa V.M., and Pasternack A.I. Evaluation of plasma cystatin C as a marker for glomerular filtration rate in patients with type 2 diabetes. Clin Nephrol 52 (1999) 363-370
24. Price C.P., and Finney H. Developments in the assessment of glomerular filtration rate. Clin Chim Acta 297 (2000) 55-66
25. Mishra J., Dent C., Tarabishi R., Mitsnefes M.M., Ma Q., Kelly C., et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365 (2005) 1231-1238
26. Akowuah E., Wilde P., Angelini G., and Bryan A.J. Systemic inflammatory response after endoluminal stenting of the descending thoracic aorta. Interact Cardiovasc Thorac Surg 6 (2007) 741-743
27. Eggebrecht H., Mehta R.H., Metozounve H., Huptas S., Herold U., Jakob H.G., and Erbel R. Clinical implications of systemic inflammatory response syndrome following thoracic aortic stent-graft placement. J Endovasc Ther 15 (2008) 135-143
28. Gabriel E.A., Locali R.F., Romano C.C., Duarte A.J., Palma J.H., and Buffolo E. Analysis of the inflammatory response in endovascular treatment of aortic aneurysms. Eur J Cardiothorac Surg 31 (2007) 406-412